Page 78 - Coronavirus Vaccine

Covid cases in children rose in Omicron wave in Europe, shows data

The data shows children aged 15 and below were more vulnerable to the Omicron wave, as they witnessed higher rates of infections in European countries

Cadila, Torrent get licence to make generic version of Pfizer's Covid pill

Pharma firms enter into licensing agreement with Medicine Patent Pool to use nirmatrelvir compound for making PAXLOVID

China cuts mandatory quarantine period for recovered Covid patients

Recovered patients are now only required to monitor their health in a seven-day home quarantine besides taking a Covid-19 test after leaving hospital, Zhang said

Biolexis to collaborate with Akston Biosciences for Covid-19 vaccine

Biolexis, a division of Stelis Biopharma, and Akston Biosciences have inked a licensing, manufacturing and commercialisation agreement regarding a COVID-19 vaccine. In a joint statement, the two companies said they will collaborate for the production and sales of Akston's AKS-452, a protein subunit COVID-19 vaccine. Under the agreement, Biolexis gained the right to manufacture and commercialise AKS-452 (branded as AmbiVax-CTM) in India and over 130 countries in Asia, Latin America, and Africa, largely covering the low-and middle-income countries (LMICs). Biolexis will also leverage the capabilities of Strides Group for launching this vaccine across regions where the group has a deep market presence and established relationships. Last year, the board of Strides Pharma Science had approved the demerger of its biotech business under Stelis Biopharma. "We are very excited to partner with Akston on AmbiVax-CTM, which is a first-of-its-kind COVID-19 vaccine developed for all parts of th

Ukraine war: WHO delays assessment of Russia's Sputnik Covid vaccine

The World Health Organization (WHO) has delayed the assessment process for granting emergency use authorisation to Russia's Sputnik V vaccine against Covid, in the wake of its invasion of Ukraine.

Data story: India logs 2,539 new cases; tally crosses 43-million mark

India has so far administered 1,808,024,147 vaccine doses. That is 4204.56 per cent of its total caseload, and 128.9 per cent of its population

German govt approves procurement of Covid-19 vaccines until 2029

The German government has approved contracts worth $3.15 billion for the purchase of Covid-19 vaccines until 2029.

Over 2.6 lakh in 12-14 yr segment get Covid vaccine on first day of drive

As India began inoculation for children aged between 12 to 14 years on Wednesday, over 2.6 lakh of this age group vaccinated with first dose of Covid vaccine on the first day.

Slow start to coronavirus vaccination drive for 12-14-year age group

The upcoming Holi weekend could also to be a dampener for the drive

Biological E prices Corbevax at Rs 800 a dose, plans 100 mn shots

Plans to test vaccine on six-month old infants; seeks EUA for 5- to 12-yr-old children

Over 260,000 doses of 'Corbevax' administered to children aged 12-14 yrs

As of March 1, 2021, there were 47 mn children aged 12 and 13 years in India

LIVE: Biden says US to give Ukraine drones, anti-aircraft systems

US President Joe Biden on Wednesday said the United States was offering an additional $800 million in security assistance to Ukraine to combat Russia's invasion

WTO DG welcomes breakthrough on Covid-19 vaccine waiver

WTO Director-General Ngozi Okonjo-Iweala welcomed breakthrough among four member countries - India, South Africa, EU US - on a waiver of TRIP agreement for the production of Covid-19 vaccines.

WHO says rise in global Covid cases is the tip of the iceberg

'Surges are to be expected particularly in areas where measures to prevent transmission have been lifted,' says WHO head

US, EU, India and South Africa make progress on Covid vaccine IPR waiver

The roadblock: Backing of 164 members of the WTO required--rejection by just one country could still block an accord

Confident of getting EUA for use of Corbevax in 5-12 years: Biological E

Biological E Ltd on Wednesday expressed confidence over getting emergency use authorisation for use of its Corbevax anti-COVID vaccine in children in the age group of 5-12 years.

Tepid response on day 1 of Covid vaccination for 12-14 years group in Delhi

The first day of the Covid vaccination drive for 12-14 year-old children saw a lukewarm response with the vaccinators hoping for a better turnout during the weekend when the schools are closed.

Covid-19: New deaths reported fell by 17% last week, but cases rising

The number of new coronavirus deaths reported worldwide fell by 17% in the last week while COVID infections rose, reversing a decline in cases that first began in January, according to WHO

Covid vaccination of children in 12-14 yr-olds begins; low turnout on day 1

Covid vaccination of children in 12-14 years age group started in Delhi on Wednesday amid a steady decline in new coronavirus cases being reported in the city

Global public health leaders urge G20 to ensure Covid vaccine equity

Global public health leaders urge G20 to take an action on vaccine equity, saying only 10% of population in low-income nations have received 1 dose of vaccine with nearly 80% in high-income nations